LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 110 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $89,304 | +89.8% | 81,930 | +298.7% | 0.00% | – |
| Q2 2023 | $47,055 | -55.5% | 20,548 | -52.8% | 0.00% | – |
| Q1 2023 | $105,761 | +219.5% | 43,523 | +151.1% | 0.00% | – |
| Q4 2022 | $33,102 | -60.1% | 17,331 | -49.8% | 0.00% | – |
| Q3 2022 | $83,000 | +102.4% | 34,541 | +75.1% | 0.00% | – |
| Q1 2022 | $41,000 | -78.5% | 19,723 | -59.3% | 0.00% | – |
| Q4 2021 | $191,000 | -27.7% | 48,467 | -11.6% | 0.00% | – |
| Q3 2021 | $264,000 | +60.0% | 54,820 | +52.7% | 0.00% | – |
| Q2 2021 | $165,000 | +24.1% | 35,911 | +58.4% | 0.00% | – |
| Q1 2021 | $133,000 | +682.4% | 22,676 | +88.8% | 0.00% | – |
| Q3 2020 | $17,000 | -52.8% | 12,011 | -33.8% | 0.00% | – |
| Q2 2020 | $36,000 | -37.9% | 18,147 | +29.7% | 0.00% | – |
| Q4 2019 | $58,000 | -68.5% | 13,991 | -77.1% | 0.00% | – |
| Q3 2019 | $184,000 | – | 61,166 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $34,786,000 | 99.98% |
| Artal Group S.A. | 57,517,978 | $463,019,000 | 19.93% |
| MASTERS CAPITAL MANAGEMENT LLC | 1,129,708 | $9,094,000 | 0.30% |
| Rhenman & Partners Asset Management AB | 170,915 | $1,376,000 | 0.16% |
| Round Table Services, LLC | 21,611 | $174,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $287,000 | 0.10% |
| FALCON POINT CAPITAL, LLC | 37,039 | $298,000 | 0.10% |
| SABBY MANAGEMENT, LLC | 318,775 | $2,566,000 | 0.09% |
| WILLIAM HARRIS INVESTORS INC | 39,495 | $318,000 | 0.09% |
| HOWARD HUGHES MEDICAL INSTITUTE | 51,520 | $415,000 | 0.09% |